pyrroles has been researched along with pyrimidinones in 149 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (3.36) | 18.7374 |
1990's | 10 (6.71) | 18.2507 |
2000's | 70 (46.98) | 29.6817 |
2010's | 54 (36.24) | 24.3611 |
2020's | 10 (6.71) | 2.80 |
Authors | Studies |
---|---|
Panzone, G; Schiatti, P; Selva, D; Tarzia, G | 1 |
Bahaji, EH; Couquelet, J; Harraga, S; Panouse-Perrin, J; Rubat, C; Tronche, P | 1 |
Bisagni, E; Legraverend, M; Ngongo-Tekam, RM; Zerial, A | 1 |
Brown, PR; Parks, RE | 1 |
Muzik, H; Paterson, AR; Warnick, CT | 1 |
Freeman, JJ; Kosh, JW; Powers, DL; Sowell, JW | 1 |
Garcia, GA; Hoops, GC; Townsend, LB | 2 |
Ficner, R; Reuter, K; Romier, C; Suck, D | 1 |
Hirota, K; Sajiki, H; Sako, M; Sawada, M | 1 |
Bagdassarian, CK; Furneaux, RH; Miles, RW; Schramm, VL; Tyler, PC | 1 |
Furneaux, RH; Girvin, ME; Grubmeyer, C; Kicska, G; Li, CM; Schramm, VL; Tyler, PC; Xu, Y | 1 |
Almo, SC; Furneaux, RH; Grubmeyer, C; Li, CM; Schramm, VL; Shi, W; Tyler, PC | 1 |
Almo, SC; Cahill, SM; Furneaux, RH; Girvin, ME; Grubmeyer, C; Li, CM; Schramm, VL; Shi, W; Tyler, PC | 1 |
Evans, GB; Furneaux, RH; Miles, RW; Parkin, DW; Schramm, VL; Tyler, PC | 1 |
Almo, SC; Furneaux, RH; Grubmeyer, C; Li, CM; Munagala, NR; Schramm, VL; Shi, W; Tyler, PC; Wang, CC | 1 |
Munagala, N; Sarver, AE; Wang, CC | 1 |
Angeletti, RH; Kicska, G; Miles, RW; Nieves, E; Schramm, VL; Wang, F | 1 |
Almo, SC; Fedorov, A; Fedorov, E; Furneaux, RH; Gainsford, GJ; Hanson, JC; Kicska, G; Larese, JZ; Schramm, VL; Shi, W; Tyler, PC | 1 |
Ficner, R; Garcia, GA; Gerber, HD; Goodenough-Lashua, DM; Grädler, U; Klebe, G; Reuter, K; Stubbs, MT | 1 |
Fairchild, C; Furneaux, RH; Hörig, H; Kaufman, HL; Kicska, GA; Long, L; Schramm, VL; Tyler, PC | 1 |
Ananth, SL; Bantia, S; Horn, LL; Hutchison, TL; Kilpatrick, JM; Miller, PJ; Montgomery, JA; Morris, PE; Parker, CD; Sandhu, JS | 1 |
Angeletti, RH; Grubmeyer, C; Nieves, E; Schramm, VL; Shi, W; Wang, F | 1 |
Basso, LA; Blanchard, JS; Furneaux, RH; Santos, DS; Schramm, VL; Shi, W; Tyler, PC | 1 |
Almo, SC; Basso, LA; Blanchard, JS; Furneaux, RH; Santos, DS; Schramm, VL; Shi, W; Tyler, PC | 1 |
Evans, GB; Furneaux, RH; Hutchison, TL; Kezar, HS; Morris, PE; Schramm, VL; Tyler, PC | 1 |
Evans, GB; Furneaux, RH; Kicska, GA; Kim, K; Schramm, VL; Tyler, PC | 1 |
Chen, C; Connors, PJ; Gao, Y; Gross, TD; Ling, N; Reinhart, GJ; Saunders, J; Struthers, RS; Wilcoxen, K; Zhu, YF | 1 |
Chen, C; Connors, PJ; Gao, Y; Gross, TD; Guo, Z; Reinhart, GJ; Saunders, J; Struthers, RS; Tucci, FC; Wilcoxen, K; Xie, Q; Zhu, YF | 1 |
Brower, JO; Lightner, DA | 1 |
Schramm, VL | 4 |
Ananth, SL; Babu, YS; Banti, S; Horn, LL; Miller, PJ; Parker, CD; Sandhu, JS | 1 |
Chen, C; Connors, PJ; Gross, TD; Guo, Z; Reinhart, GJ; Saunders, J; Struthers, RS; Tucci, FC; Wang, X; Zhu, YF | 1 |
Almo, SC; Cahill, SM; Evans, GB; Fedorov, A; Furneaux, RH; Kicska, GA; Lewandowicz, A; Schramm, VL; Shi, W; Tyler, PC | 1 |
Dineshkumar, TK; Subbulakshmi, C; Thanedar, S; Varshney, U | 1 |
Cervetto, L; Demontis, GC; Longoni, B; Macchia, B; Macchia, M; Minutolo, F; Orlandini, E; Ortore, G; Papi, C; Sbrana, A | 1 |
Babu, YS; Bennett, JC; Kilpatrick, JM; Moore, DR; Morris, PE; Phillips, D; Serota, DG | 1 |
Basso, LA; Cahill, SM; Evans, GB; Furneaux, RH; Girvin, ME; Grubmeyer, C; Lewandowicz, A; McDermott, A; Santos, DS; Sauve, AA; Schramm, VL; Tyler, PC; Zech, SG | 1 |
Almo, SC; Basso, LA; Evans, GB; Furneaux, RH; Lewandowicz, A; Santos, DS; Schramm, VL; Shi, W; Tyler, PC | 1 |
Bae, DS; Campain, JA; Handa, RJ; Yang, RS | 1 |
Ananth, SL; Bantia, S; Horn, LL; Parker, CD; Upshaw, R | 1 |
Gill, MJ; Mah Ming, JB | 1 |
Evans, GB; Furneaux, RH; Lewandowicz, A; Schramm, VL; Tyler, PC | 1 |
Basso, LA; Canduri, F; Dias, MV; Filgueira de Azevedo, W; Marangoni dos Santos, D; Mendes, MA; Palma, MS; Pereira, JH; Santos, DS; Silva, RG | 1 |
Evans, GB; Furneaux, RH; Schramm, VL; Tyler, PC | 1 |
Aronov, PA; Green, PG; Ngo, M; Patterson, TJ; Reznikova, TV; Rice, RH | 1 |
Almo, SC; Evans, GB; Furneaux, RH; Schramm, VL; Shi, W; Singh, V; Tyler, PC | 1 |
Cahill, SM; Callender, RH; Deng, H; Furneaux, RH; Girvin, ME; Lewandowicz, A; Schramm, VL; Tyler, PC | 1 |
Almo, SC; Evans, GB; Furneaux, RH; Kicska, GA; Kim, K; Lewandowicz, A; Schramm, VL; Shi, W; Ting, LM; Tyler, PC | 1 |
Evans, GB; Furneaux, RH; Schramm, VL; Singh, V; Tyler, PC | 1 |
Callender, R; Deng, H; Lewandowicz, A; Schramm, VL | 1 |
Gregus, Z; Németi, B | 1 |
Basso, LA; Canduri, F; de Azevedo, WF; Fadel, V; Palma, MS; Santos, DS | 1 |
Cornell, KA; Evans, GB; Furneaux, RH; Howell, PL; Lee, JE; Riscoe, MK; Schramm, VL; Singh, V; Tyler, PC | 1 |
Lewandowicz, A | 1 |
Evans, GB; Furneaux, RH; Kim, K; Lenz, DH; Lewandowicz, A; Mee, S; Painter, GF; Ringia, EA; Schramm, VL; Ting, LM; Tyler, PC; Zubkova, OV | 1 |
Basso, LA; Canduri, F; de Azevedo, WF; dos Santos, DM; Palma, MS; Santos, DS; Silva, RG | 1 |
Baize, MW; Demuth, TP; Ellis, CD; Fancher, AN; Laufersweiler, MC; Lu, W; O'Neil, SV; Oppong, KA; Soper, DL; Suchanek, MK; Wang, RL; Wang, Y; Wos, JA | 1 |
Gangjee, A; Kisliuk, RL; McGuire, JJ; Zeng, Y | 1 |
Ayres, M; Bantia, S; Davisson, J; Du, M; Faderl, S; Gandhi, V; Harman, L; Kantarjian, H; Kilpatrick, JM; Plunkett, W; Thomas, D; Wierda, WG | 1 |
Boiadjiev, SE; Lightner, DA; McDonagh, AF; Norona, WS; Woydziak, ZR | 1 |
Angeli, P; Cagnotto, A; Marucci, G; Materia, L; Mennini, T; Mereghetti, I; Modica, M; Pittalà, V; Romeo, G; Russo, F; Salerno, L; Siracusa, MA | 1 |
Gangjee, A; Jain, HD; Kisliuk, RL; Lin, X; McGuire, JJ; Phan, J; Song, X | 1 |
Brown, S; de Crécy-Lagard, V; Iwata-Reuyl, D; Lee, B; Reddy, RR; Schimmel, P; Swairjo, MA; Van Lanen, SG | 1 |
Hilmy, KM | 1 |
Barlow, J; Steyaert, J; Versées, W | 1 |
Balakrishnan, K; Gandhi, V; Keating, MJ; Nimmanapalli, R; Ravandi, F | 1 |
Alvarez, R; Botta, M; Corelli, F; Focher, F; Ghiron, C; Lossani, A; Manetti, F; Mugnaini, C; Semeraro, T; Valensin, S | 1 |
Gandhi, V; Ravandi, F | 1 |
Barrick, JE; Breaker, RR; Iwata-Reuyl, D; Jona, I; Kim, JN; Lee, BW; Lim, J; Regulski, EE; Ritwik, A; Roth, A; Welz, R; Winkler, WC | 1 |
Garcia, GA; Hurt, JK; Olgen, S | 1 |
Alfani, E; Altucci, L; Brosch, G; Di Noia, A; Galanello, R; Jelicic, K; Mai, A; Massa, S; Migliaccio, AR; Migliaccio, G; Nebbioso, A; Rotili, D; Valente, S | 1 |
Brown, T; Fox, KR; Gerrard, SR; Srinivasan, N | 1 |
Chang, CY; Chang, TY; Chao, YS; Coumar, MS; Hsieh, HP; Hsu, JT; Leou, JS; Lin, WH; Tan, UK; Wu, JS; Wu, SY | 1 |
Breaker, RR; Chervin, SM; Garcia, GA; Meyer, MM; Roth, A | 1 |
Delso, I; Merino, P; Tejero, T | 1 |
Cicmil, N; Huang, RH | 1 |
Fawcett, JP; Gu, J; Jiang, Y; Kong, J; Tang, Y; Teng, G; Wang, J; Wang, Y | 1 |
Feifel, R; Hawtin, S; Heng, R; Huppertz, C; Koch, G; Moebitz, H; Revesz, L; Scheufler, C; Schlapbach, A; Velcicky, J; Waelchli, R | 1 |
Bandarian, V; Krucinska, J; Spitale, RC; Torelli, AT; Wedekind, JE | 1 |
Kreutz, C; Lang, K; Micura, R; Polacek, N; Rieder, U | 1 |
Li, C; Liu, F | 1 |
Gangjee, A; Ihnat, MA; Kurup, S; Shenoy, SS; Thorpe, JE | 1 |
Kreutz, C; Micura, R; Rieder, U | 1 |
Guo, ZJ; Wu, N; Xu, Y | 1 |
Brooks, AF; Chen, YC; Garcia, GA; Goodenough-Lashua, DM; Kittendorf, JD; Showalter, HD | 1 |
Dračínský, M; Krečmerová, M; Mařák, D; Otmar, M; Votruba, I | 1 |
Cassera, MB; Hazleton, KZ; Schramm, VL; Zhang, Y | 1 |
Dewhurst, J; Petrone, PM; Pomerantz, AK; Tommasi, R; Whitehead, L | 1 |
Al-Hashimi, HM; Brooks, CL; Eichhorn, CD; Feng, J; Suddala, KC; Walter, NG | 1 |
Eriksson, H; Georgievska, B; Poewe, W; Stefanova, N; Wenning, GK | 1 |
Bayrakdarian, M; Buon, C; Cantin, LD; Grazzini, E; Hu, YJ; Labrecque, J; Leung, C; Luo, X; Martino, G; Paré, M; Payza, K; Popovic, N; Projean, D; Santhakumar, V; Tomaszewski, MJ; Walpole, C; Yu, XH | 1 |
Brooks, AF; Garcia, GA; Showalter, HD; Vélez-Martínez, CS | 1 |
Gerber, HD; Klebe, G | 1 |
Hanefeld, U; Hollmann, F; Moeller, K; Nguyen, GS | 1 |
Egger, S; Gruber, K; Klempier, N; Kratzer, R; Lyskowski, A; Nidetzky, B; Petschacher, B; Steinkellner, G; Wilding, B; Winkler, M | 1 |
Al-Hashimi, HM; Brooks, CL; Eichhorn, CD; Feng, J; Liberman, JA; Mustoe, AM; Rinaldi, AJ; Suddala, KC; Walter, NG; Wedekind, JE | 1 |
Deng, Z; Hong, K; Liu, Y; Ma, M; Wang, K; Xu, D; Zhou, T | 1 |
Bonte, D; Melcher, K; Sasi, NK; Soon, FF; Tiwari, K; Wang, T; Weinreich, M; Xu, HE | 1 |
Bogue, JT; Jenkins, JL; Liberman, JA; Salim, M; Wedekind, JE | 1 |
Bergman, L; Farde, L; Halldin, C; Johnström, P; Malmquist, J; Varnäs, K | 1 |
Clinch, K; Evans, GB; Freitas, EO; Guan, R; Meyer-Fernandes, JR; Nico, D; Palatnik-de-Sousa, CB; Schramm, VL; Tyler, PC | 1 |
Aytenfisu, A; Belashov, IA; Chan, D; Liberman, JA; Mathews, DH; Salim, M; Spitale, RC; Suddala, KC; Walter, NG; Wedekind, JE | 1 |
Dixon, N; Leigh, J; Lowe, PT; Micklefield, J; Robinson, CJ; Vincent, HA; Wu, MC | 1 |
Jia, L; Peng, S; Wang, L; Wu, C; Yang, J; Yang, X; Yin, J; Yuan, Z; Zhao, S | 1 |
Amini, N; Budd, S; Cselényi, Z; Farde, L; Halldin, C; Helin, S; Johnström, P; Jucaite, A; Kirjavainen, A; Kugler, AR; Minkwitz, M; Posener, JA; Rinne, JO; Svenningsson, P; Varnäs, K; Varrone, A | 1 |
Georgievska, B; Kaindlstorfer, C; Kugler, AR; Mather, RJ; Poewe, W; Sommer, P; Stefanova, N; Wenning, GK | 1 |
Akiyama, R; Anderson, JL; Denny, CT; Federman, N; Park, A; Tap, WD | 1 |
Bridgeman, VL; Foo, S; Frentzas, S; Gore, M; Larkin, J; Nathan, MR; Nathan, PD; Powles, T; Preece, N; Reynolds, AR; Springer, CJ; Vasudev, NS; Vermeulen, PB; Wan, E; Welti, JC | 1 |
Gu, J; Peng, W; Sun, H; Sun, L; Sun, Y; Wang, J; Yang, Y | 1 |
Alvarez, J; Bon Ramos, A; Iwata-Reuyl, D; Mei, X; Samanta, U; Swairjo, MA | 1 |
Altman, MD; Chen, D; Childers, KK; Davies, IW; Haidle, A; Harsch, A; Hayashi, M; Hou, Y; Hutton, M; Jewell, JP; Katz, JD; Munoz, B; Munshi, S; Northrup, A; Nuthall, H; Stanton, MG; Su, HP; Szewczak, A; Warren, L; Zabierek, AA | 1 |
Cil, O; Donowitz, M; Gillespie, AM; Lee, S; Lin, R; Phuan, PW; Tradtrantip, L; Tse, M; Verkman, AS; Yin, J; Zachos, NC | 1 |
Altman, MD; Chen, D; Childers, KK; Davies, IW; Haidle, AM; Harsch, A; Hayashi, M; Hou, Y; Hutton, M; Jewell, JP; Katz, JD; Munoz, B; Northrup, A; Nuthall, H; Stanton, MG; Szewczak, A; Warren, L; Zabierek, AA | 1 |
Seeliger, JC; Topp, S; Van Vlack, ER | 1 |
Chevot, F; Connon, SJ; Cotter, M; Cunningham, C; Fergus, C; Kelly, VP; Mills, KH; Southern, JM; Varghese, S | 1 |
Ayele, T; Choi, YJ; Deventer, KV; Gibala, KS; Resendiz, MJE | 1 |
Gaboriau, D; Quachthithu, H; Rainey, MD; Santocanale, C | 1 |
Berg, A; Dinavahi, SS; Drabick, JJ; Gowda, R; Neves, RI; Noory, MA; Robertson, GP | 1 |
Famulok, M; Kerzhner, M; Matsuoka, H; Schiemann, O; Wuebben, C | 1 |
Al-Huniti, N; Li, J; Li, Y; Mullen, JA; Savage, A; Taylor, W; Tong, X; Xu, H; Zhou, D | 1 |
Andrade, CH; Bianco Júnior, C; Carvalho, LJM; Castro, RN; Daniel-Ribeiro, CT; Domingues, LHP; Graebin, CS; Moreira Filho, JT; Neves, BJ; Rogerio, KR | 1 |
Andrs, M; Gorecki, L; Havelek, R; Jun, D; Korabecny, J; Polednikova, M; Pospisilova, M; Rezacova, M; Seifrtova, M; Tichy, A; Vejrychova, K | 1 |
Coquel, F; Lin, YL; MacKeigan, JP; Pasero, P; Sasi, NK; Weinreich, M | 1 |
Belashov, IA; Ermolenko, DN; Ling, C; Salim, M; Warnasooriya, C; Wedekind, JE | 1 |
Frener, M; Lusser, A; Micura, R; Neuner, E | 1 |
Sinumvayo, JP; Tuyishime, P; Zhao, C | 1 |
Cil, O; Duan, T; Thiagarajah, JR; Verkman, AS | 1 |
Baldini, E; Bernardini, G; Jacomelli, G; Micheli, V; Mugnaini, C; Santucci, A | 1 |
Barchi, JJ; Boer, RE; Connelly, CM; Ferré-D'Amaré, AR; Moon, MH; Numata, T; Schneekloth, JS; Sinniah, RS | 1 |
Brennan, PE; Chen, C; Cheng, W; Ding, B; Huang, L; Li, H; Li, L; Niu, L; Seupel, R; Wu, C; Yang, S | 1 |
Cil, O; Donowitz, M; Duan, T; Lin, R; Sarker, R; Tse, CM; Verkman, AS | 1 |
Hou, XJ; Wang, YF; Wu, CF; Yang, JY; Zhang, Z; Zhu, L | 1 |
Beaufils, F; Bohnacker, T; Borsari, C; Dall'Asen, A; Fabbro, D; Hebeisen, P; Hillmann, P; Jackson, E; Langlois, JB; Melone, A; Rageot, D; Sele, AM; Wymann, MP | 1 |
Tytgat, GNJ | 1 |
Bandyopadhyay, T; Ganguly, B; Ghosh, S; Jana, K; Wakchaure, PD | 1 |
Dutta, D; Wedekind, JE | 1 |
Balamkundu, S; Carstens, AB; Cui, L; de Crécy-Lagard, V; Dedon, PC; Fa Lui, C; Gnanakalai, S; Hansen, LH; Hatfull, GF; Hillebrand, R; Hutinet, G; Jacobs-Sera, D; Kot, W; Lee, YJ; Moineau, S; Neelakandan, R; Sassanfar, M; Tremblay, D; Weigele, P | 1 |
Chatterjee, S; Daher, M; Lund, PE; Walter, NG | 1 |
Kierzek, E; Kierzek, R | 1 |
Adderley, T; Christopher, G; Irwin, MS; Kano, Y; Kee, L; Ladumor, Y; Ohh, M; Robinson, CM; Valencia-Sama, I | 1 |
Carstens, AB; Cui, L; de Crécy-Lagard, V; Dedon, PC; Hansen, LH; Hutinet, G; Kot, W; Moineau, S; Nielsen, TK; Olsen, NS; Swairjo, MA | 1 |
Belinsky, MG; D'Souza, J; DeMatteo, R; Devarajan, K; Duncan, JS; Einarson, MB; Heinrich, MC; Johnson, KJ; Klug, L; Kozinova, M; Litwin, S; Rink, L; Sharipova, D; von Mehren, M; Ye, S; Zhou, Y | 1 |
Demizu, Y; Imamura, Y; Kittaka, A; Kohara, M; Kurihara, M; Kuwata, K; Moriya, SS; Shibasaki, H; Sugiyama, T | 1 |
Blau, ME; Cavender, CE; Jenkins, JL; Mathews, DH; Schroeder, GM; Wedekind, JE | 1 |
Fischer, TR; Grimm, M; Helm, M; Kallert, E; Kersten, C; Schneider, S | 1 |
8 review(s) available for pyrroles and pyrimidinones
Article | Year |
---|---|
Development of transition state analogues of purine nucleoside phosphorylase as anti-T-cell agents.
Topics: Animals; Antineoplastic Agents; Drug Design; Enzyme Inhibitors; Humans; Leukemia, T-Cell; Mice; Nucleosides; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Static Electricity; T-Lymphocytes; Transplantation, Heterologous | 2002 |
Immucillins as antibiotics for T-cell proliferation and malaria.
Topics: Animals; Anti-Bacterial Agents; Cell Proliferation; Deoxyguanosine; Erythrocytes; Humans; Hypoxanthine; Kinetics; Lymphocyte Activation; Malaria; Models, Chemical; Phenotype; Plasmodium falciparum; Purine Nucleosides; Purines; Pyrimidinones; Pyrroles; T-Lymphocytes | 2004 |
Enzymatic transition states: thermodynamics, dynamics and analogue design.
Topics: Animals; Catalysis; Crystallography, X-Ray; Deuterium; Drug Design; Enzyme Inhibitors; Enzymes; Humans; Hydrogen; Hydrogen Bonding; Inosine; Kinetics; Models, Molecular; Motion; Protein Conformation; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Static Electricity; Substrate Specificity; Thermodynamics | 2005 |
[Tight binding transition state analogues of purine nucleoside phosphorylase--meaning, design and properties].
Topics: Animals; Enzyme Inhibitors; Humans; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Structure-Activity Relationship | 2004 |
Novel purine nucleoside analogues for T-cell-lineage acute lymphoblastic leukaemia and lymphoma.
Topics: Adult; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Child; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Deoxyguanosine; Drug Design; Drug Screening Assays, Antitumor; Drugs, Investigational; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Experimental; Lymphoma, T-Cell; Mice; Neoplasm Proteins; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; T-Lymphocytes | 2006 |
Current developments in the synthesis and biological activity of aza-C-nucleosides: immucillins and related compounds.
Topics: Adenine; Adenosine; Aza Compounds; Glycoside Hydrolases; N-Glycosyl Hydrolases; Nucleosides; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Pyrrolidines | 2008 |
Purine and pyrimidine pathways as targets in Plasmodium falciparum.
Topics: Antimalarials; Binding Sites; Drug Design; Enzyme Inhibitors; Humans; Malaria, Falciparum; Models, Molecular; Plasmodium falciparum; Protein Binding; Protozoan Proteins; Purine Nucleosides; Purines; Pyrimidines; Pyrimidinones; Pyrroles; Substrate Specificity | 2011 |
Recent advances and future trends of riboswitches: attractive regulatory tools.
Topics: Aptamers, Nucleotide; Aptamers, Peptide; Bacteria; Bacterial Proteins; Gene Expression Regulation, Bacterial; Genes, Bacterial; Glycine; Ligands; Pyrimidinones; Pyrroles; Riboswitch; RNA, Bacterial | 2018 |
2 trial(s) available for pyrroles and pyrimidinones
Article | Year |
---|---|
A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine).
Topics: Adult; Aged; Deoxyguanine Nucleotides; Enzyme Inhibitors; Female; Humans; Leukemia, Lymphoid; Male; Middle Aged; Molecular Structure; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Treatment Outcome | 2005 |
Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease.
Topics: Aged; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Female; Fluorine Radioisotopes; Follow-Up Studies; Humans; Male; Microglia; Middle Aged; Parkinson Disease; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Protein Binding; Pyrimidines; Pyrimidinones; Pyrroles; Receptors, GABA; Severity of Illness Index | 2015 |
139 other study(ies) available for pyrroles and pyrimidinones
Article | Year |
---|---|
Synthesis and anti-inflammatory properties of some pyrrolo(1H,3H)[3,4-d]pyrimidin-2-ones and pyrrolo(1H,6H)[3,4-d]pyrimidin-2-ones.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Aspirin; Edema; Female; Indomethacin; Male; Mice; Pyrimidinones; Pyrroles; Rats | 1979 |
Studies on immunostimulating derivatives: synthesis of some pyrrolo[1,2-c]pyrimidines.
Topics: Adjuvants, Immunologic; Animals; Humans; Hypnotics and Sedatives; In Vitro Techniques; Mice; Motor Activity; Pyrimidines; Pyrimidinones; Pyrroles; T-Lymphocytes | 1991 |
(+/-)-2-Amino-3,4-dihydro-7-[2,3-dihydroxy-4-(hydroxymethyl)-1- cyclopentyl]-7H-pyrrolo[2,3-d]pyrimidin-4-ones: new carbocyclic analogues of 7-deazaguanosine with antiviral activity.
Topics: Animals; Antiviral Agents; Chemical Phenomena; Chemistry; DNA Viruses; Herpes Simplex; Mice; Pyrimidinones; Pyrroles; RNA Viruses; Simplexvirus; Structure-Activity Relationship; Virus Replication | 1985 |
Incorporation of nucleosides into the nucleotide pools of human erythrocytes. Adenosine and its analogs.
Topics: Adenine Nucleotides; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Aminohydrolases; Antibiotics, Antineoplastic; Aza Compounds; Carbohydrate Metabolism; Deoxyadenosines; Erythrocytes; Fluorine; Humans; Inosine; Mercaptopurine; Nucleosides; Phosphotransferases; Pyrazoles; Pyrimidines; Pyrimidinones; Pyrroles; Ribonucleosides; Structure-Activity Relationship | 1973 |
Interference with nucleoside transport in mouse lymphoma cells proliferating in culture.
Topics: Adenosine; Animals; Ascitic Fluid; Aza Compounds; Biological Transport; Bromodeoxyuridine; Carbon Isotopes; Cell Division; Cell-Free System; Cells, Cultured; Guanosine; Inosine; Lymphoma; Male; Mercaptopurine; Methotrexate; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Pyrazoles; Pyrimidinones; Pyrroles; Ribonucleosides; Thymidine; Time Factors; Transplantation, Homologous | 1972 |
Anticonvulsant properties of selected pyrrolo[2,3-d]pyrimidine-2,4-diones and intermediates.
Topics: Animals; Anticonvulsants; Electroshock; Male; Mice; Pentylenetetrazole; Phenytoin; Pyrimidinones; Pyrroles; Seizures; Solubility; Structure-Activity Relationship; Trimethadione | 1980 |
Mechanism-based inactivation of tRNA-guanine transglycosylase from Escherichia coli by 2-amino-5-(fluoromethyl)pyrrolo[2,3-d]pyrimidin-4 (3H)-one.
Topics: Enzyme Inhibitors; Escherichia coli; Pentosyltransferases; Pyrimidinones; Pyrroles; RNA, Transfer | 1995 |
tRNA-guanine transglycosylase from Escherichia coli: structure-activity studies investigating the role of the aminomethyl substituent of the heterocyclic substrate PreQ1.
Topics: Binding, Competitive; Enzyme Inhibitors; Escherichia coli; Guanine; Kinetics; Molecular Structure; Pentosyltransferases; Purines; Pyrimidinones; Pyrroles; RNA, Transfer; Structure-Activity Relationship; Substrate Specificity | 1995 |
Crystal structure of tRNA-guanine transglycosylase: RNA modification by base exchange.
Topics: Amino Acid Sequence; Anticodon; Catalysis; Crystallography, X-Ray; Guanine; Metalloproteins; Models, Molecular; Molecular Sequence Data; Nucleic Acid Precursors; Pentosyltransferases; Pyrimidinones; Pyrroles; Recombinant Proteins; RNA, Transfer; Sequence Alignment; Sequence Homology, Amino Acid; Structure-Activity Relationship; Zinc; Zymomonas | 1996 |
Synthesis of 6-aminouracils and pyrrolo[2,3-d]pyrimidine-2,4-diones and their inhibitory effect on thymidine phosphorylase.
Topics: Antimetabolites, Antineoplastic; Cell Division; Drug Design; Enzyme Inhibitors; Female; Humans; Neovascularization, Pathologic; Pregnancy; Pyrimidinones; Pyrroles; Thymidine Phosphorylase; Tumor Cells, Cultured; Uracil | 1997 |
One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase.
Topics: Animals; Cattle; Enzyme Inhibitors; Humans; Kinetics; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Structure-Activity Relationship; Substrate Specificity; T-Lymphocytes | 1998 |
Transition-state analogs as inhibitors of human and malarial hypoxanthine-guanine phosphoribosyltransferases.
Topics: Animals; Binding Sites; Catalysis; Diphosphates; Drug Design; Enzyme Inhibitors; Guanosine Monophosphate; Humans; Hydrogen Bonding; Hypoxanthine; Hypoxanthine Phosphoribosyltransferase; Inosine Monophosphate; Kinetics; Magnesium Compounds; Nuclear Magnetic Resonance, Biomolecular; Phosphoribosyl Pyrophosphate; Phosphorylation; Plasmodium falciparum; Protein Binding; Protons; Purine Nucleosides; Pyrimidinones; Pyrroles | 1999 |
The 2.0 A structure of human hypoxanthine-guanine phosphoribosyltransferase in complex with a transition-state analog inhibitor.
Topics: Binding Sites; Catalytic Domain; Crystallization; Crystallography, X-Ray; Diphosphates; Electrons; Enzyme Inhibitors; Humans; Hydrogen Bonding; Hypoxanthine Phosphoribosyltransferase; Ions; Magnesium; Magnesium Compounds; Models, Molecular; Molecular Sequence Data; Nitrogen; Oxygen; Phosphates; Protein Binding; Protein Structure, Secondary; Pyrimidinones; Pyrroles; Solvents | 1999 |
The 2.0 A structure of malarial purine phosphoribosyltransferase in complex with a transition-state analogue inhibitor.
Topics: Animals; Catalytic Domain; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Macromolecular Substances; Models, Molecular; Nuclear Magnetic Resonance, Biomolecular; Pentosyltransferases; Plasmodium falciparum; Protein Conformation; Protein Folding; Protein Structure, Secondary; Protons; Purine Nucleosides; Pyrimidinones; Pyrroles | 1999 |
Iminoribitol transition state analogue inhibitors of protozoan nucleoside hydrolases.
Topics: Animals; Crithidia fasciculata; Enzyme Inhibitors; Guanosine; Hydrogen Bonding; Inosine; Macromolecular Substances; N-Glycosyl Hydrolases; Protozoan Proteins; Purines; Pyrimidinones; Pyrroles; Ribitol; Ribose; Structure-Activity Relationship; Substrate Specificity | 1999 |
Crystal structures of Giardia lamblia guanine phosphoribosyltransferase at 1.75 A(,).
Topics: Animals; Binding Sites; Crystallography, X-Ray; Dimerization; Enzyme Inhibitors; Giardia lamblia; Hypoxanthine Phosphoribosyltransferase; Models, Molecular; Molecular Conformation; Pyrimidinones; Pyrroles; Recombinant Proteins | 2000 |
Converting the guanine phosphoribosyltransferase from Giardia lamblia to a hypoxanthine-guanine phosphoribosyltransferase.
Topics: Amino Acid Sequence; Animals; Binding Sites; Crystallography, X-Ray; Giardia lamblia; Giardiasis; Humans; Hypoxanthine Phosphoribosyltransferase; Kinetics; Magnesium; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Phosphates; Protein Conformation; Pyrimidinones; Pyrroles; Structure-Activity Relationship | 2000 |
Immucillin-H binding to purine nucleoside phosphorylase reduces dynamic solvent exchange.
Topics: Amino Acid Sequence; Mass Spectrometry; Models, Molecular; Molecular Sequence Data; Protein Binding; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Solvents | 2000 |
Transition state structure of purine nucleoside phosphorylase and principles of atomic motion in enzymatic catalysis.
Topics: Animals; Binding Sites; Catalysis; Cattle; Crystallography, X-Ray; Deuterium; Electron Transport; Enzyme Inhibitors; Hydrolysis; Inosine; Macromolecular Substances; Motion; Phosphates; Protein Conformation; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles | 2001 |
A new target for shigellosis: rational design and crystallographic studies of inhibitors of tRNA-guanine transglycosylase.
Topics: Binding Sites; Computer Simulation; Crystallography, X-Ray; Databases as Topic; Drug Design; Dysentery, Bacillary; Enzyme Inhibitors; Guanine; Kinetics; Models, Molecular; Molecular Structure; Pentosyltransferases; Phthalazines; Pyrimidinones; Pyrroles; Shigella flexneri; Software; Static Electricity; Thermodynamics; Zymomonas | 2001 |
Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes.
Topics: Apoptosis; Cell Division; Deoxyguanine Nucleotides; Enzyme Inhibitors; Humans; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; T-Lymphocytes; Tumor Cells, Cultured | 2001 |
Purine nucleoside phosphorylase inhibitor BCX-1777 (Immucillin-H)--a novel potent and orally active immunosuppressive agent.
Topics: Administration, Oral; Animals; Biological Availability; Enzyme Inhibitors; Graft vs Host Reaction; Guanosine Triphosphate; Immunosuppressive Agents; Indicators and Reagents; Injections, Intravenous; Lymphocyte Culture Test, Mixed; Mice; Mice, Inbred BALB C; Mice, SCID; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Survival Analysis; T-Lymphocytes | 2001 |
A transition-state analogue reduces protein dynamics in hypoxanthine-guanine phosphoribosyltransferase.
Topics: Amino Acid Sequence; Binding Sites; Catalytic Domain; Chromatography, High Pressure Liquid; Deuterium; Diphosphates; Enzyme Inhibitors; Humans; Hypoxanthine Phosphoribosyltransferase; Isoleucine; Leucine; Macromolecular Substances; Magnesium; Magnesium Compounds; Mass Spectrometry; Molecular Sequence Data; Pepsin A; Peptide Fragments; Phenylalanine; Protons; Pyrimidinones; Pyrroles | 2001 |
Purine nucleoside phosphorylase from Mycobacterium tuberculosis. Analysis of inhibition by a transition-state analogue and dissection by parts.
Topics: Binding, Competitive; Catalysis; Cloning, Molecular; Enzyme Inhibitors; Gene Expression Regulation, Bacterial; Hydrogen-Ion Concentration; Kinetics; Molecular Weight; Mycobacterium tuberculosis; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Recombinant Proteins | 2001 |
Structures of purine nucleoside phosphorylase from Mycobacterium tuberculosis in complexes with immucillin-H and its pieces.
Topics: Actinomycetales; Animals; Binding Sites; Catalysis; Cattle; Enzyme Inhibitors; Enzyme Stability; Escherichia coli; Macromolecular Substances; Models, Molecular; Mycobacterium tuberculosis; Phosphates; Protein Conformation; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles | 2001 |
Addition of lithiated 9-deazapurine derivatives to a carbohydrate cyclic imine: convergent synthesis of the aza-C-nucleoside immucillins.
Topics: Imines; Lithium; Purines; Pyrimidine Nucleosides; Pyrimidinones; Pyrroles | 2001 |
Purine-less death in Plasmodium falciparum induced by immucillin-H, a transition state analogue of purine nucleoside phosphorylase.
Topics: Animals; Biological Transport; Cell Death; Enzyme Inhibitors; Erythrocytes; Humans; Hypoxanthine; Kinetics; Models, Biological; Plasmodium falciparum; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Purines; Pyrimidinones; Pyrroles; Time Factors | 2002 |
Initial structure-activity relationship studies of a novel series of pyrrolo[1,2-a]pyrimid-7-ones as GnRH receptor antagonists.
Topics: Animals; Humans; Indicators and Reagents; Kinetics; Pyrimidinones; Pyrroles; Radioligand Assay; Rats; Receptors, LHRH; Structure-Activity Relationship | 2002 |
A novel synthesis of 2-arylpyrrolo[1,2-a]pyrimid-7-ones and their structure-activity relationships as potent GnRH receptor antagonists.
Topics: Animals; Humans; Indicators and Reagents; Kinetics; Pyrimidinones; Pyrroles; Radioligand Assay; Rats; Receptors, LHRH; Structure-Activity Relationship | 2002 |
Synthesis and spectroscopic properties of a new class of strongly fluorescent dipyrrinones.
Topics: Bilirubin; Chemistry, Organic; Crystallography, X-Ray; Fluorescent Dyes; Heterocyclic Compounds, 3-Ring; Magnetic Resonance Spectroscopy; Molecular Conformation; Molecular Structure; Pyrimidinones; Pyrroles; Spectrophotometry, Ultraviolet; Structure-Activity Relationship | 2002 |
Comparison of in vivo efficacy of BCX-1777 and cyclosporin in xenogeneic graft-vs.-host disease: the role of dGTP in antiproliferative action of BCX-1777.
Topics: Animals; Cyclosporine; Deoxyguanine Nucleotides; Dogs; Drug Therapy, Combination; Graft vs Host Disease; Growth Inhibitors; Humans; Immunosuppressive Agents; Lymphocytes; Macaca fascicularis; Mice; Mice, Inbred BALB C; Mice, SCID; Purine Nucleosides; Pyrimidinones; Pyrroles; Rats; Rats, Sprague-Dawley; Survival Rate; Transplantation, Heterologous | 2002 |
A novel synthesis of 7-aryl-8-fluoro-pyrrolo[1,2-a]pyrimid-4-ones as potent, stable GnRH receptor antagonists.
Topics: Calcium; Cell Line; Cyclization; Drug Stability; Humans; Models, Molecular; Protein Binding; Pyrimidinones; Pyrroles; Receptors, LHRH; Recombinant Proteins; Structure-Activity Relationship; Thermodynamics | 2002 |
Atomic dissection of the hydrogen bond network for transition-state analogue binding to purine nucleoside phosphorylase.
Topics: Animals; Asparagine; Binding Sites; Catalysis; Cattle; Crystallography, X-Ray; Enzyme Inhibitors; Glutamic Acid; Hydrogen Bonding; Hydrogen-Ion Concentration; Hypoxanthine; Imines; Nuclear Magnetic Resonance, Biomolecular; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Ribonucleosides; Static Electricity; Substrate Specificity; Thermodynamics | 2002 |
An unexpected absence of queuosine modification in the tRNAs of an Escherichia coli B strain.
Topics: Electrophoresis, Polyacrylamide Gel; Escherichia coli; Nucleoside Q; Pentosyltransferases; Pyrimidinones; Pyrroles; RNA, Bacterial; RNA, Transfer, Tyr; Urea | 2002 |
New N-n-propyl-substituted 3-aryl- and 3-cyclohexylpiperidines as partial agonists at the D4 dopamine receptor.
Topics: Animals; Binding, Competitive; Corpus Striatum; Crystallography, X-Ray; Dopamine Agonists; Guanine Nucleotides; Guinea Pigs; In Vitro Techniques; Male; Melatonin; Piperidines; Purine Nucleosides; Pyrimidinones; Pyrroles; Radioligand Assay; Receptors, Dopamine D2; Receptors, Dopamine D4; Retina; Structure-Activity Relationship | 2003 |
Intravenous and oral pharmacokinetic study of BCX-1777, a novel purine nucleoside phosphorylase transition-state inhibitor. In vivo effects on blood 2'-deoxyguanosine in primates.
Topics: Administration, Oral; Animals; Area Under Curve; Biological Availability; Deoxyguanosine; Enzyme Inhibitors; Erythrocytes; Injections, Intravenous; Inosine; Macaca fascicularis; Male; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles | 2003 |
Ionic states of substrates and transition state analogues at the catalytic sites of N-ribosyltransferases.
Topics: Catalytic Domain; Guanosine; Guanosine Monophosphate; Humans; Hydrogen-Ion Concentration; Hypoxanthine Phosphoribosyltransferase; In Vitro Techniques; Ions; Kinetics; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Phosphorylation; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Recombinant Proteins; Substrate Specificity | 2003 |
Over-the-barrier transition state analogues and crystal structure with Mycobacterium tuberculosis purine nucleoside phosphorylase.
Topics: Catalytic Domain; Crystallography, X-Ray; Inosine; Kinetics; Models, Molecular; Molecular Mimicry; Mycobacterium tuberculosis; Protein Conformation; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Static Electricity; Substrate Specificity | 2003 |
Gene expression patterns as potential molecular biomarkers for malignant transformation in human keratinocytes treated with MNNG, arsenic, or a metal mixture.
Topics: Animals; Arsenates; Bile; Biotransformation; Chromatography, High Pressure Liquid; Dithiothreitol; Enzyme Inhibitors; Erythrocytes; Humans; In Vitro Techniques; Inosine; Male; Oxidation-Reduction; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Rats; Rats, Wistar; Spectrophotometry, Atomic; Sulfhydryl Reagents | 2003 |
Mechanism of inhibition of T-acute lymphoblastic leukemia cells by PNP inhibitor--BCX-1777.
Topics: Apoptosis; Cell Division; Cell Line; Culture Media; Half-Life; HIV Reverse Transcriptase; Humans; Lamivudine; Leukemia-Lymphoma, Adult T-Cell; Lymphocytes; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Reverse Transcriptase Inhibitors; Stavudine | 2003 |
Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV.
Topics: Adult; Anti-Bacterial Agents; Atorvastatin; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Heptanoic Acids; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lopinavir; Male; Pyrimidinones; Pyrroles; Rhabdomyolysis; Ritonavir | 2003 |
Exploring structure-activity relationships of transition state analogues of human purine nucleoside phosphorylase.
Topics: Animals; Cattle; Enzyme Inhibitors; Humans; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Structure-Activity Relationship | 2003 |
Structural basis for inhibition of human PNP by immucillin-H.
Topics: Crystallography, X-Ray; Enzyme Inhibitors; Humans; Ligands; Models, Molecular; Protein Conformation; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles | 2003 |
Synthesis of a transition state analogue inhibitor of purine nucleoside phosphorylase via the Mannich reaction.
Topics: Amines; Enzyme Inhibitors; Humans; Purine-Nucleoside Phosphorylase; Purines; Pyrimidinones; Pyrroles | 2003 |
Transition state analogues for enzymes of nucleic acid metabolism.
Topics: Animals; Cattle; Enzyme Inhibitors; Enzymes; Humans; Kinetics; Nucleic Acids; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Ricin | 2003 |
Biological activity of inorganic arsenic and antimony reflects oxidation state in cultured human keratinocytes.
Topics: Animals; Antimony; Arsenic; Biotransformation; Cattle; Cell Line; Dose-Response Relationship, Drug; Enzyme Induction; Enzyme Inhibitors; Fibroblasts; Guanine; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Keratinocytes; Membrane Proteins; Oxidation-Reduction; Protein Precursors; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Spleen | 2003 |
Picomolar transition state analogue inhibitors of human 5'-methylthioadenosine phosphorylase and X-ray structure with MT-immucillin-A.
Topics: Binding Sites; Catalysis; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Phosphates; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Recombinant Proteins; Ribitol | 2004 |
Assignment of downfield proton resonances in purine nucleoside phosphorylase immucillin-H complex by saturation-transferred NOEs.
Topics: Binding, Competitive; Catalysis; Enzyme Activation; Enzyme Inhibitors; Humans; Hydrogen Bonding; Nuclear Magnetic Resonance, Biomolecular; Protein Binding; Protons; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Recombinant Proteins; Solutions; Thermodynamics | 2004 |
Plasmodium falciparum purine nucleoside phosphorylase: crystal structures, immucillin inhibitors, and dual catalytic function.
Topics: Animals; Catalysis; Catalytic Domain; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Hydrophobic and Hydrophilic Interactions; Methylthioinosine; Molecular Structure; Plasmodium falciparum; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles | 2004 |
Targeting the polyamine pathway with transition-state analogue inhibitors of 5'-methylthioadenosine phosphorylase.
Topics: Adenine; Humans; Polyamines; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Pyrrolidines; Stereoisomerism; Structure-Activity Relationship | 2004 |
Activating the phosphate nucleophile at the catalytic site of purine nucleoside phosphorylase: a vibrational spectroscopic study.
Topics: Animals; Binding Sites; Catalysis; Cattle; Humans; Hydrogen Bonding; Kinetics; Organophosphates; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Thermodynamics | 2004 |
Glutathione-dependent reduction of arsenate in human erythrocytes--a process independent of purine nucleoside phosphorylase.
Topics: Arsenates; Arsenite Transporting ATPases; Blood Glucose; Dithiothreitol; Erythrocytes; Ferricyanides; Glucose Oxidase; Glutathione; Humans; In Vitro Techniques; Inosine; Ion Pumps; Multienzyme Complexes; NADP; Oxidation-Reduction; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Pyruvic Acid; Spectrophotometry, Atomic | 2004 |
New catalytic mechanism for human purine nucleoside phosphorylase.
Topics: Acyclovir; Binding Sites; Catalysis; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Models, Molecular; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles | 2005 |
Structural rationale for the affinity of pico- and femtomolar transition state analogues of Escherichia coli 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase.
Topics: Deoxyadenosines; Enzyme Inhibitors; Escherichia coli; Models, Molecular; N-Glycosyl Hydrolases; Purine Nucleosides; Pyrimidinones; Pyrroles; Thionucleosides | 2005 |
Energetic mapping of transition state analogue interactions with human and Plasmodium falciparum purine nucleoside phosphorylases.
Topics: Animals; Aspartic Acid; Cattle; Humans; Hydrogen-Ion Concentration; Kinetics; Models, Chemical; Plasmodium falciparum; Polyamines; Protein Binding; Protein Structure, Tertiary; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Purines; Pyrimidinones; Pyrroles; Static Electricity; Substrate Specificity; T-Lymphocytes | 2005 |
Structure of human PNP complexed with ligands.
Topics: Azaguanine; Binding Sites; Crystallography, X-Ray; Guanine; Guanosine; Humans; Inosine; Ligands; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles | 2005 |
Synthesis and evaluation of tricyclic pyrrolopyrimidinones as dipeptide mimetics: inhibition of interleukin-1beta-converting enzyme.
Topics: Caspase Inhibitors; Dipeptides; Enzyme Inhibitors; Heterocyclic Compounds, 3-Ring; Humans; Immunologic Factors; Inhibitory Concentration 50; Molecular Mimicry; Monocytes; Pyrimidinones; Pyrroles; Structure-Activity Relationship | 2005 |
Synthesis of classical, four-carbon bridged 5-substituted furo[2,3-d]pyrimidine and 6-substituted pyrrolo[2,3-d]pyrimidine analogues as antifolates.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Folic Acid Antagonists; Furans; Glutamic Acid; Humans; Peptide Synthases; Pyrimidines; Pyrimidinones; Pyrroles; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase | 2005 |
Synthesis and hepatic transport of strongly fluorescent cholephilic dipyrrinones.
Topics: Animals; Bile; Bilirubin; Colchicine; Drug Evaluation, Preclinical; Feasibility Studies; Fluorescent Dyes; Liver; Liver Diseases; Male; Mitochondrial Proteins; Pyrimidinones; Pyrroles; Rats; Rats, Gunn; Rats, Sprague-Dawley; Ribosomal Proteins; Saccharomyces cerevisiae Proteins; Spectrometry, Fluorescence; Sulfonic Acids; Urine | 2005 |
3-Arylpiperazinylethyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione derivatives as novel, high-affinity and selective alpha(1)-adrenoceptor ligands.
Topics: Chlorine; Dopamine Agents; Dose-Response Relationship, Drug; Humans; Kinetics; Ligands; Magnetic Resonance Spectroscopy; Models, Chemical; Piperazines; Protein Binding; Pyrimidinones; Pyrroles; Receptors, Adrenergic, alpha-1; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Time Factors | 2006 |
Dual inhibitors of thymidylate synthase and dihydrofolate reductase as antitumor agents: design, synthesis, and biological evaluation of classical and nonclassical pyrrolo[2,3-d]pyrimidine antifolates(1).
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Drug Screening Assays, Antitumor; Escherichia coli; Folic Acid Antagonists; Glutamates; Humans; Models, Molecular; Pyrimidines; Pyrimidinones; Pyrroles; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Thermodynamics; Thymidylate Synthase | 2006 |
Crystallization and preliminary X-ray characterization of the nitrile reductase QueF: a queuosine-biosynthesis enzyme.
Topics: Bacillus subtilis; Catalysis; Computational Biology; Crystallization; Crystallography, X-Ray; GTP Cyclohydrolase; Guanine; Models, Chemical; Models, Molecular; NADP; Nucleoside Q; Oxidoreductases; Protein Conformation; Protein Isoforms; Protein Structure, Tertiary; Pyrimidinones; Pyrroles; RNA Processing, Post-Transcriptional; RNA, Transfer; X-Ray Diffraction | 2005 |
Synthesis of non-nucleosides: 7- and 1,3-substituents of new pyrrolo[2,3-d]pyrimidin-4-ones on antiviral activity.
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Herpesvirus 2, Human; Microbial Sensitivity Tests; Pyrimidinones; Pyrroles; Structure-Activity Relationship; Vero Cells; Viral Plaque Assay | 2006 |
Transition-state complex of the purine-specific nucleoside hydrolase of T. vivax: enzyme conformational changes and implications for catalysis.
Topics: Animals; Binding Sites; Crystallography, X-Ray; Ligands; Models, Molecular; Molecular Structure; N-Glycosyl Hydrolases; Protein Folding; Protein Structure, Quaternary; Protein Structure, Secondary; Purine Nucleosides; Pyrimidinones; Pyrroles; Trypanosoma vivax | 2006 |
Forodesine, an inhibitor of purine nucleoside phosphorylase, induces apoptosis in chronic lymphocytic leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; B-Lymphocytes; Caspases; DNA Damage; Enzyme Inhibitors; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Mitochondria; Phosphorylation; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; T-Lymphocytes; Tumor Suppressor Protein p53 | 2006 |
Simplified analogues of immucillin-G retain potent human purine nucleoside phosphorylase inhibitory activity.
Topics: Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Piperidines; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Pyrrolidines; Structure-Activity Relationship | 2006 |
A riboswitch selective for the queuosine precursor preQ1 contains an unusually small aptamer domain.
Topics: 5' Untranslated Regions; Aptamers, Nucleotide; Bacillus subtilis; Base Pairing; Base Sequence; Conserved Sequence; Dialysis; Gene Expression Regulation, Bacterial; Genes, Bacterial; Molecular Sequence Data; Nucleoside Q; Phylogeny; Pyrimidinones; Pyrroles; Regulatory Sequences, Ribonucleic Acid; RNA, Bacterial | 2007 |
Site-specific modification of Shigella flexneri virF mRNA by tRNA-guanine transglycosylase in vitro.
Topics: Amino Acid Sequence; Anticodon; Bacterial Proteins; Base Sequence; Escherichia coli; Escherichia coli Proteins; Kinetics; Molecular Sequence Data; Pentosyltransferases; Plasmids; Pyrimidinones; Pyrroles; RNA, Messenger; RNA, Transfer, Tyr; Shigella flexneri; Substrate Specificity; Transcription Factors; Transcription, Genetic | 2007 |
Identification of two new synthetic histone deacetylase inhibitors that modulate globin gene expression in erythroid cells from healthy donors and patients with thalassemia.
Topics: Blood Donors; Enzyme Inhibitors; Erythroblasts; Gene Expression; Globins; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Pyrimidinones; Pyrroles; Thalassemia; Tubulin | 2007 |
CG base pair recognition within DNA triple helices using N-methyl-3H-pyrrolo[2,3-d]pyrimidin-2(7H)-one nucleoside analogues.
Topics: Base Pairing; Cytosine; DNA; Guanine; Hydrogen Bonding; Nucleosides; Pyrimidinones; Pyrroles | 2007 |
Aurora kinase A inhibitors: identification, SAR exploration and molecular modeling of 6,7-dihydro-4H-pyrazolo-[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-dione scaffold.
Topics: Aurora Kinases; Binding Sites; Models, Molecular; Molecular Structure; Protein Serine-Threonine Kinases; Pyrazoles; Pyrimidinones; Pyrroles; Structure-Activity Relationship | 2008 |
Confirmation of a second natural preQ1 aptamer class in Streptococcaceae bacteria.
Topics: 5' Untranslated Regions; Aptamers, Nucleotide; Base Sequence; Binding Sites; Computational Biology; Genes, Bacterial; Kinetics; Ligands; Models, Molecular; Molecular Sequence Data; Mutation; Nucleic Acid Conformation; Phylogeny; Pyrimidinones; Pyrroles; RNA, Bacterial; Sequence Homology, Nucleic Acid; Streptococcaceae; Streptococcus pneumoniae | 2008 |
Crystal structure of QueC from Bacillus subtilis: an enzyme involved in preQ1 biosynthesis.
Topics: Bacillus subtilis; Bacterial Proteins; Crystallography, X-Ray; Models, Molecular; Protein Structure, Secondary; Pyrimidinones; Pyrroles | 2008 |
A rapid and sensitive LC-MS/MS assay to quantify yonkenafil in rat plasma with application to preclinical pharmacokinetics studies.
Topics: Acetates; Administration, Oral; Administration, Sublingual; Animals; Biological Availability; Buffers; Chromatography, Liquid; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Evaluation, Preclinical; Drug Stability; Fasting; Hydrogen-Ion Concentration; Injections, Intravenous; Male; Methanol; Molecular Structure; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Pyrimidinones; Pyrroles; Quality Control; Random Allocation; Rats; Rats, Wistar; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Time Factors | 2008 |
Pyrrolo-pyrimidones: a novel class of MK2 inhibitors with potent cellular activity.
Topics: Arthritis, Rheumatoid; Combinatorial Chemistry Techniques; Cytokines; Dose-Response Relationship, Drug; Drug Design; HSP27 Heat-Shock Proteins; Humans; Intracellular Signaling Peptides and Proteins; Leukocytes, Mononuclear; Lipopolysaccharides; Molecular Structure; Monocytes; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Pyrimidinones; Pyrroles; Tumor Necrosis Factor-alpha | 2008 |
The structural basis for recognition of the PreQ0 metabolite by an unusually small riboswitch aptamer domain.
Topics: Aptamers, Nucleotide; Bacillus subtilis; Base Pairing; Binding Sites; Crystallography, X-Ray; Electrons; Hydrogen Bonding; Ligands; Models, Chemical; Models, Molecular; Nucleic Acid Conformation; Protein Conformation; Protein Structure, Tertiary; Pyrimidinones; Pyrroles; Thermoanaerobacter | 2009 |
Evidence for pseudoknot formation of class I preQ1 riboswitch aptamers.
Topics: 5' Untranslated Regions; Aptamers, Nucleotide; Base Pairing; Base Sequence; Fusobacterium nucleatum; Mutation; Nucleic Acid Conformation; Pyrimidinones; Pyrroles; Regulatory Sequences, Ribonucleic Acid; RNA, Bacterial; RNA, Transfer | 2009 |
Intramolecular formal [4 + 2] cycloaddition of nitriles with amides triggered by TMSOTf/Et3N: highly efficient construction of pyrrolo[1,2-a]pyrimidin-4(6H)-ones.
Topics: Amides; Cyclization; Ethylamines; Mesylates; Molecular Structure; Nitriles; Pyrimidinones; Pyrroles; Stereoisomerism; Trimethylsilyl Compounds | 2009 |
Synthesis and biological activity of N(4)-phenylsubstituted-6-(2,4-dichloro phenylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic and antitumor agents.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Diamines; Indoles; Male; Melanoma; Mice; Mice, Nude; Molecular Structure; Phosphorylation; Pyrimidines; Pyrimidinones; Pyrroles; Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2 | 2010 |
Folding of a transcriptionally acting preQ1 riboswitch.
Topics: Aptamers, Nucleotide; Base Sequence; Fusobacterium nucleatum; Kinetics; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Nucleic Acid Conformation; Pyrimidinones; Pyrroles; RNA, Bacterial; RNA, Messenger; Spectrometry, Fluorescence | 2010 |
Two new amide alkaloids with anti-leukaemia activities from Aconitum taipeicum.
Topics: Aconitum; Alkaloids; Animals; Antineoplastic Agents, Phytogenic; HL-60 Cells; Humans; Leukemia; Molecular Structure; Plant Roots; Pyrimidinones; Pyrroles | 2010 |
Evolution of eukaryal tRNA-guanine transglycosylase: insight gained from the heterocyclic substrate recognition by the wild-type and mutant human and Escherichia coli tRNA-guanine transglycosylases.
Topics: Amino Acid Sequence; Escherichia coli; Evolution, Molecular; Guanine; Humans; Kinetics; Molecular Sequence Data; Mutation; Pentosyltransferases; Phylogeny; Pyrimidinones; Pyrroles; Sequence Homology, Amino Acid; Substrate Specificity | 2011 |
8-Aza-7,9-dideazaxanthine acyclic nucleoside phosphonate inhibitors of thymidine phosphorylase.
Topics: Enzyme Inhibitors; Escherichia coli; Female; Humans; Placenta; Pregnancy; Pyrimidinones; Pyrroles; Recombinant Proteins; Structure-Activity Relationship; Thymidine Phosphorylase | 2011 |
Atomic-scale characterization of conformational changes in the preQ₁ riboswitch aptamer upon ligand binding.
Topics: 2-Aminopurine; Aptamers, Nucleotide; Molecular Dynamics Simulation; Nucleic Acid Conformation; Pyrimidinones; Pyrroles; Riboswitch; RNA; Spectrometry, Fluorescence; Surface Properties | 2011 |
Unraveling the structural complexity in a single-stranded RNA tail: implications for efficient ligand binding in the prequeuosine riboswitch.
Topics: Adenine; Ligands; Molecular Dynamics Simulation; Mutation; Nuclear Magnetic Resonance, Biomolecular; Nucleic Acid Conformation; Pyrimidinones; Pyrroles; Riboswitch; RNA; RNA Stability | 2012 |
Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model.
Topics: Aged; alpha-Synuclein; Animals; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gliosis; Humans; Male; Mice; Mice, Transgenic; Microglia; Middle Aged; Motor Activity; Multiple System Atrophy; Nerve Degeneration; Peroxidase; Pyrimidinones; Pyrroles | 2012 |
Discovery of P2X3 selective antagonists for the treatment of chronic pain.
Topics: Analgesics; Animals; Chronic Pain; Dose-Response Relationship, Drug; High-Throughput Screening Assays; Humans; Injections, Spinal; Injections, Subcutaneous; Purinergic P2 Receptor Antagonists; Pyrimidinones; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X3; Small Molecule Libraries | 2012 |
Investigating the prevalence of queuine in Escherichia coli RNA via incorporation of the tritium-labeled precursor, preQ(1).
Topics: Acrylic Resins; Electrophoresis, Agar Gel; Escherichia coli; Guanine; Isotope Labeling; Pyrimidinones; Pyrroles; RNA Processing, Post-Transcriptional; RNA, Bacterial; RNA, Transfer; Tritium | 2012 |
Concise and efficient syntheses of preQ1 base, Q base, and (ent)-Q base.
Topics: Guanine; Molecular Structure; Pyrimidinones; Pyrroles | 2012 |
Expression and characterization of the nitrile reductase queF from E. coli.
Topics: Bacillus subtilis; Base Sequence; Catalytic Domain; Enzyme Stability; Escherichia coli K12; Escherichia coli Proteins; Genes, Bacterial; Hydrogen-Ion Concentration; Kinetics; Models, Molecular; Molecular Sequence Data; NADP; Nuclear Magnetic Resonance, Biomolecular; Nucleoside Q; Oxidoreductases; Protein Conformation; Pyrimidinones; Pyrroles; Recombinant Fusion Proteins; Substrate Specificity; Temperature | 2013 |
Targeting the substrate binding site of E. coli nitrile reductase QueF by modeling, substrate and enzyme engineering.
Topics: Binding Sites; Catalysis; Catalytic Domain; Escherichia coli; Escherichia coli Proteins; Nucleoside Q; Oxidation-Reduction; Oxidoreductases; Pyrimidinones; Pyrroles; Substrate Specificity | 2013 |
Single transcriptional and translational preQ1 riboswitches adopt similar pre-folded ensembles that follow distinct folding pathways into the same ligand-bound structure.
Topics: Bacillus subtilis; Fluorescence Resonance Energy Transfer; Ligands; Nucleic Acid Conformation; Protein Biosynthesis; Pyrimidinones; Pyrroles; Riboswitch; RNA Folding; Thermoanaerobacter; Transcription, Genetic | 2013 |
PreQ0 base, an unusual metabolite with anti-cancer activity from Streptomyces qinglanensis 172205.
Topics: Antineoplastic Agents; Cell Proliferation; Computational Biology; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; Hep G2 Cells; Humans; Molecular Structure; Pyrimidinones; Pyrroles; Streptomyces; Structure-Activity Relationship | 2015 |
The potent Cdc7-Dbf4 (DDK) kinase inhibitor XL413 has limited activity in many cancer cell lines and discovery of potential new DDK inhibitor scaffolds.
Topics: Apoptosis; Biological Availability; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Drug Repositioning; Gene Expression Regulation, Neoplastic; HCT116 Cells; HeLa Cells; Humans; Piperidones; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrimidinones; Pyrroles | 2014 |
ITC analysis of ligand binding to preQ₁ riboswitches.
Topics: Calorimetry; Ligands; Models, Molecular; Pyrimidinones; Pyrroles; Riboswitch; Thermodynamics | 2014 |
Development of rapid multistep carbon-11 radiosynthesis of the myeloperoxidase inhibitor AZD3241 to assess brain exposure by PET microdosing.
Topics: Animals; Brain; Carbon Radioisotopes; Dose-Response Relationship, Radiation; Female; Humans; Macaca fascicularis; Magnetic Resonance Imaging; Male; Peroxidase; Positron-Emission Tomography; Pyrimidinones; Pyrroles; Radiopharmaceuticals | 2015 |
Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro.
Topics: Adenine; Adenosine; Animals; Antiprotozoal Agents; Cell Proliferation; Enzyme Inhibitors; Female; Humans; In Vitro Techniques; Kinetics; Leishmania infantum; Leishmania mexicana; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; N-Glycosyl Hydrolases; Purine Nucleosides; Pyrimidinones; Pyrroles; Pyrrolidines | 2015 |
Structural analysis of a class III preQ1 riboswitch reveals an aptamer distant from a ribosome-binding site regulated by fast dynamics.
Topics: Aptamers, Nucleotide; Base Sequence; Binding Sites; Clostridium; Crystallography, X-Ray; Kinetics; Molecular Dynamics Simulation; Molecular Sequence Data; Nucleoside Q; Pyrimidinones; Pyrroles; Ribosomes; Riboswitch; RNA Folding; RNA, Bacterial; Thermodynamics | 2015 |
Rational Re-engineering of a Transcriptional Silencing PreQ1 Riboswitch.
Topics: Aptamers, Nucleotide; Bacillus subtilis; Base Sequence; Gene Expression Regulation, Bacterial; Gene Silencing; Genetic Engineering; Mutagenesis; Pyrimidinones; Pyrroles; Riboswitch; Synthetic Biology; Transcriptional Activation | 2015 |
NF-κB Upregulates Type 5 Phosphodiesterase in N9 Microglial Cells: Inhibition by Sildenafil and Yonkenafil.
Topics: Animals; Cell Line; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Enzymologic; Humans; Inflammation Mediators; Lipopolysaccharides; Mice; Microglia; Neurotoxins; NF-kappa B; Phosphodiesterase Inhibitors; Pyrimidinones; Pyrroles; RNA Interference; RNA, Messenger; Sildenafil Citrate; Up-Regulation | 2016 |
Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications.
Topics: alpha-Synuclein; Animals; Brain; Disease Models, Animal; Enzyme Inhibitors; Humans; Male; Mice, Transgenic; Microglia; Motor Activity; Multiple System Atrophy; Myelin Proteolipid Protein; Neurons; Neuroprotective Agents; Nitro Compounds; Peroxidase; Propionates; Pyrimidinones; Pyrroles; Severity of Illness Index; Treatment Outcome | 2015 |
Evaluation of In Vitro Activity of the Class I PI3K Inhibitor Buparlisib (BKM120) in Pediatric Bone and Soft Tissue Sarcomas.
Topics: Aminopyridines; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Class I Phosphatidylinositol 3-Kinases; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Humans; Mechanistic Target of Rapamycin Complex 1; Morpholines; Multiprotein Complexes; Mutation; Osteosarcoma; Phosphorylation; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyridones; Pyrimidines; Pyrimidinones; Pyrroles; Sarcoma; Signal Transduction; TOR Serine-Threonine Kinases | 2015 |
Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Drug Synergism; Endothelial Cells; Female; Humans; Indoles; Kidney Neoplasms; MAP Kinase Signaling System; Neovascularization, Pathologic; Protein Kinase Inhibitors; Pyridones; Pyrimidinones; Pyrroles; Sunitinib; Von Hippel-Lindau Tumor Suppressor Protein; Xenograft Model Antitumor Assays | 2016 |
Rapid and sensitive liquid chromatography with tandem mass spectrometry method for the simultaneous quantification of yonkenafil and its major metabolites in rat plasma.
Topics: Animals; Chromatography, High Pressure Liquid; Molecular Structure; Plasma; Pyrimidinones; Pyrroles; Rats; Rats, Wistar; Sensitivity and Specificity; Tandem Mass Spectrometry | 2016 |
Crystal structure of the archaeosine synthase QueF-like-Insights into amidino transfer and tRNA recognition by the tunnel fold.
Topics: Amidinotransferases; Amino Acid Sequence; Archaeal Proteins; Catalytic Domain; Cloning, Molecular; Crystallography, X-Ray; Escherichia coli; Gene Expression; Guanosine; Molecular Docking Simulation; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Protein Multimerization; Protein Subunits; Pyrimidinones; Pyrobaculum; Pyrroles; Recombinant Proteins; RNA Processing, Post-Transcriptional; RNA, Archaeal; RNA, Transfer; Sequence Alignment; Sequence Homology, Amino Acid; Substrate Specificity | 2017 |
Structure guided design of a series of selective pyrrolopyrimidinone MARK inhibitors.
Topics: Alzheimer Disease; Cell Line; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Design; Humans; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrimidinones; Pyrroles; Structure-Activity Relationship | 2017 |
Benzopyrimido-pyrrolo-oxazine-dione CFTR inhibitor (R)-BPO-27 for antisecretory therapy of diarrheas caused by bacterial enterotoxins.
Topics: Animals; Cystic Fibrosis Transmembrane Conductance Regulator; Diarrhea; Dose-Response Relationship, Drug; Female; Humans; Intestines; Mice; Molecular Structure; Oxazines; Pyrimidinones; Pyrroles | 2017 |
MARK inhibitors: Declaring a No-Go decision on a chemical series based on extensive DMPK experimentation.
Topics: Alzheimer Disease; Animals; Dose-Response Relationship, Drug; Humans; Isoenzymes; Molecular Structure; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrimidinones; Pyrroles; Rats; Structure-Activity Relationship | 2017 |
Characterization of Engineered PreQ1 Riboswitches for Inducible Gene Regulation in Mycobacteria.
Topics: Bacillus subtilis; Base Sequence; Gene Expression Regulation, Bacterial; Genetic Engineering; Lacticaseibacillus rhamnosus; Mycobacterium smegmatis; Nucleoside Q; Pyrimidinones; Pyrroles; Riboswitch; Thermoanaerobacter | 2017 |
In vivo modification of tRNA with an artificial nucleobase leads to full disease remission in an animal model of multiple sclerosis.
Topics: Animals; Brain; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Genetic Therapy; Mice, Inbred C57BL; Multiple Sclerosis; Pentosyltransferases; Pyrimidinones; Pyrroles; RNA, Transfer; Thioguanine | 2017 |
Biophysical properties, thermal stability and functional impact of 8-oxo-7,8-dihydroguanine on oligonucleotides of RNA-a study of duplex, hairpins and the aptamer for preQ1 as models.
Topics: Aptamers, Nucleotide; DNA; Guanine; Inverted Repeat Sequences; Magnetic Resonance Spectroscopy; Nucleic Acid Conformation; Oligoribonucleotides; Pyrimidinones; Pyrroles | 2017 |
DNA Replication Dynamics and Cellular Responses to ATP Competitive CDC7 Kinase Inhibitors.
Topics: Adenosine Triphosphate; Binding, Competitive; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA Replication; Female; Humans; Phosphorylation; Piperidones; Protein Serine-Threonine Kinases; Pyrimidinones; Pyrroles | 2017 |
Moving Synergistically Acting Drug Combinations to the Clinic by Comparing Sequential versus Simultaneous Drug Administrations.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Administration Schedule; Drug Antagonism; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Forkhead Box Protein M1; Gene Expression Regulation, Neoplastic; Humans; Mice; Multiple Myeloma; Pyrazoles; Pyrimidines; Pyrimidinones; Pyrroles; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2018 |
High-Yield Spin Labeling of Long RNAs for Electron Paramagnetic Resonance Spectroscopy.
Topics: Aptamers, Nucleotide; Click Chemistry; Electron Spin Resonance Spectroscopy; Nucleic Acid Conformation; Pyrimidinones; Pyrroles; Riboswitch; RNA; Spin Labels | 2018 |
Population Pharmacokinetic Modeling With Enterohepatic Circulation for AZD3241 in Healthy Subjects and Patients With Multiple System Atrophy.
Topics: Adult; Aged; Bile; Enterohepatic Circulation; Female; Healthy Volunteers; Humans; Male; Middle Aged; Models, Biological; Multiple System Atrophy; Peroxidase; Pyrimidinones; Pyrroles; Random Allocation | 2018 |
Synthesis and molecular modelling studies of pyrimidinones and pyrrolo[3,4-d]-pyrimidinodiones as new antiplasmodial compounds.
Topics: Animals; Antimalarials; Drug Design; Inhibitory Concentration 50; Mice; Models, Molecular; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Pyrimidinones; Pyrroles; Structure-Activity Relationship | 2018 |
Purin-6-one and pyrrolo[2,3-d]pyrimidin-4-one derivatives as potentiating agents of doxorubicin cytotoxicity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Humans; Neoplasms; Purinones; Pyrimidinones; Pyrroles | 2018 |
DDK Has a Primary Role in Processing Stalled Replication Forks to Initiate Downstream Checkpoint Signaling.
Topics: Cell Cycle Proteins; Cell Line; Dimethyl Sulfoxide; DNA Repair Enzymes; DNA Replication; DNA, Single-Stranded; Etoposide; Exodeoxyribonucleases; Humans; Mitosis; Piperidones; Protein Serine-Threonine Kinases; Pyrimidinones; Pyrroles; Signal Transduction | 2018 |
Observation of preQ
Topics: Fluorescence Resonance Energy Transfer; Magnesium; Nucleic Acid Conformation; Nucleoside Q; Pyrimidines; Pyrimidinones; Pyrroles; Riboswitch; RNA, Transfer; Single Molecule Imaging | 2019 |
Superior cellular activities of azido- over amino-functionalized ligands for engineered preQ
Topics: Binding Sites; Escherichia coli; Gene Expression Regulation, Bacterial; Kinetics; Ligands; Nucleic Acid Conformation; Pyrimidinones; Pyrroles; Riboswitch; RNA Folding; Structure-Activity Relationship; Thermodynamics | 2018 |
Intestinal epithelial potassium channels and CFTR chloride channels activated in ErbB tyrosine kinase inhibitor diarrhea.
Topics: Acetamides; Afatinib; Animals; Cell Membrane Permeability; Clotrimazole; Colon; Cystic Fibrosis Transmembrane Conductance Regulator; Diarrhea; Disease Models, Animal; Epithelial Cells; ErbB Receptors; Female; Humans; Intestinal Mucosa; Neoplasms; Oxazines; Potassium Channel Blockers; Potassium Channels; Protein Kinase Inhibitors; Pyrimidinones; Pyrroles; Rats; Trityl Compounds | 2019 |
Inhibiting PNP for the therapy of hyperuricemia in Lesch-Nyhan disease: Preliminary in vitro studies with analogues of immucillin-G.
Topics: Allopurinol; Cells, Cultured; Enzyme Inhibitors; Humans; Hyperuricemia; Hypoxanthine; Hypoxanthine Phosphoribosyltransferase; Lesch-Nyhan Syndrome; Purine-Nucleoside Phosphorylase; Purines; Pyrimidinones; Pyrroles; Reproducibility of Results; Uric Acid; Xanthine | 2019 |
Synthetic ligands for PreQ
Topics: Aptamers, Nucleotide; Crystallography, X-Ray; Ligands; Nucleic Acid Conformation; Pyrimidinones; Pyrroles; Riboswitch; RNA Folding | 2019 |
Discovery of Pyrrolo[3,2- d]pyrimidin-4-one Derivatives as a New Class of Potent and Cell-Active Inhibitors of P300/CBP-Associated Factor Bromodomain.
Topics: Animals; Drug Discovery; Enzyme Inhibitors; Gene Expression; HEK293 Cells; Humans; Male; Mice; Microsomes, Liver; Molecular Structure; p300-CBP Transcription Factors; Protein Domains; Pyrimidinones; Pyrroles; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship | 2019 |
Inhibition of CFTR-mediated intestinal chloride secretion as potential therapy for bile acid diarrhea.
Topics: Animals; Cell Line; Cells, Cultured; Chenodeoxycholic Acid; Chlorides; Cystic Fibrosis Transmembrane Conductance Regulator; Diarrhea; Female; Humans; Intestinal Mucosa; Intestinal Secretions; Mice; Oxazines; Pyrimidinones; Pyrroles; Rats; Rats, Sprague-Dawley | 2019 |
Inhibition of PDE5 attenuates streptozotocin-induced neuroinflammation and tau hyperphosphorylation in a streptozotocin-treated rat model.
Topics: Alzheimer Disease; Animals; Disease Models, Animal; Encephalitis; Insulin; Male; Phosphodiesterase 5 Inhibitors; Phosphorylation; Pyrimidinones; Pyrroles; Rats, Wistar; Streptozocin; tau Proteins | 2019 |
A Conformational Restriction Strategy for the Identification of a Highly Selective Pyrimido-pyrrolo-oxazine mTOR Inhibitor.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Dogs; Drug Design; Humans; Inhibitory Concentration 50; Kinetics; Male; Mice; Molecular Conformation; Neoplasms; Oxazines; Protein Kinase Inhibitors; Pyrimidinones; Pyrroles; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; TOR Serine-Threonine Kinases | 2019 |
Highlights from Gastro Update Europe - Budapest June 26-27, 2019.
Topics: Celiac Disease; Clostridioides difficile; Colorectal Neoplasms; Endoscopy, Digestive System; Enterocolitis, Pseudomembranous; Foodborne Diseases; Gastroesophageal Reflux; Gastrointestinal Diseases; Humans; Pancreatic Intraductal Neoplasms; Pancreatitis; Proton Pump Inhibitors; Pyrimidinones; Pyrroles; Sulfonamides; Tetrahydroisoquinolines | 2019 |
Quantum chemical and well-tempered metadynamics study to design adenine analogs for orthogonal Preq
Topics: Adenine; Nucleic Acid Conformation; Pyrimidinones; Pyrroles; Riboswitch | 2020 |
Nucleobase mutants of a bacterial preQ
Topics: Base Sequence; Binding Sites; Gene Expression Regulation, Bacterial; Mutation; Pyrimidinones; Pyrroles; Riboswitch; RNA, Bacterial | 2020 |
7-Deazaguanine modifications protect phage DNA from host restriction systems.
Topics: Archaeal Viruses; Bacteriophages; DNA; DNA Restriction Enzymes; Guanine; Pyrimidinones; Pyrroles | 2019 |
Protein unties the pseudoknot: S1-mediated unfolding of RNA higher order structure.
Topics: 2-Aminopurine; Binding Sites; Escherichia coli; Guanine; Ligands; Nucleic Acid Conformation; Pyrimidinones; Pyrroles; Ribosomal Proteins; Ribosomes; Riboswitch; RNA; RNA Folding; Single Molecule Imaging | 2020 |
Conscious uncoupling of riboswitch functions.
Topics: Bacteria; Biophysical Phenomena; Gene Expression Regulation; Lacticaseibacillus rhamnosus; Ligands; Mutation; Nucleic Acid Conformation; Pyrimidinones; Pyrroles; Riboswitch | 2020 |
Topics: Aminopyridines; Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Genes, ras; Heterografts; Humans; Indoles; Male; MAP Kinase Signaling System; Mice, Inbred NOD; Mice, SCID; Mitogen-Activated Protein Kinase Kinases; Mutation; Neoplasm Recurrence, Local; Neuroblastoma; Piperidines; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Pyridones; Pyrimidines; Pyrimidinones; Pyrroles; Triazoles; Vemurafenib | 2020 |
Detection of preQ0 deazaguanine modifications in bacteriophage CAjan DNA using Nanopore sequencing reveals same hypermodification at two distinct DNA motifs.
Topics: Bacteriophages; Base Sequence; CRISPR-Cas Systems; DNA; DNA Restriction-Modification Enzymes; Escherichia coli; Gene Editing; Guanine; Humans; Nanopore Sequencing; Nucleotide Motifs; Pyrimidinones; Pyrroles; Siphoviridae | 2020 |
Identification of Wee1 as a target in combination with avapritinib for gastrointestinal stromal tumor treatment.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Female; Gastrointestinal Stromal Tumors; Humans; Male; Mice; Mice, SCID; Mutation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrazoles; Pyrimidinones; Pyrroles; Receptor, Platelet-Derived Growth Factor alpha; Signal Transduction; Triazines; Xenograft Model Antitumor Assays | 2021 |
Synthesis and characterization of PNA oligomers containing preQ
Topics: Molecular Structure; Peptide Nucleic Acids; Pyrimidinones; Pyrroles | 2021 |
A small RNA that cooperatively senses two stacked metabolites in one pocket for gene control.
Topics: Base Pairing; Cloning, Molecular; Crystallography, X-Ray; Escherichia coli; Gene Expression; Gene Expression Regulation, Bacterial; Genetic Vectors; Green Fluorescent Proteins; Neisseria gonorrhoeae; Nucleic Acid Conformation; Nucleoside Q; Pyrimidinones; Pyrroles; Recombinant Proteins; Riboswitch; RNA, Bacterial; RNA, Messenger | 2022 |
Protein-Based Virtual Screening Tools Applied for RNA-Ligand Docking Identify New Binders of the preQ
Topics: Ligands; Prospective Studies; Proteins; Pyrimidinones; Pyrroles; Riboswitch; RNA | 2022 |